Key result
This review discusses the mechanisms, efficacy, and safety of commonly used and emerging antithrombotic agents for secondary ischemic stroke prevention.
This review summarizes the mechanisms, efficacy, and safety of current and emerging antithrombotic agents for secondary ischemic stroke prevention.
Answers are grounded in this paper and cite their sources.
Guides antithrombotic selection for secondary ischemic stroke prevention; leaves open the need for RCTs on emerging agents.
Antithrombotic therapy plays a key role in secondary ischemic stroke prevention. A multitude of antithrombotic agents exist with varying pharmacologic, efficacy, and safety profiles. In this review, the authors discuss the mechanisms of antithrombotic therapy, summarize the data on commonly used agents, and introduce emerging antithrombotic medications. KEYWORDS Antiplatelets - anticoagulation - secondary stroke prevention - ischemic stroke
No takes yet. Share an insight, caveat, or question.
Lazzaro et al. (2010) conducted a review in Secondary ischemic stroke. Antithrombotic therapy was evaluated. This review discusses the mechanisms, efficacy, and safety of commonly used and emerging antithrombotic agents for secondary ischemic stroke prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: